Insulin-like growth factor (IGF)-binding protein 5 forms an alternative ternary complex with IGFs and the acid-labile subunit
about
Substitutions for hydrophobic amino acids in the N-terminal domains of IGFBP-3 and -5 markedly reduce IGF-I binding and alter their biologic actionsInactivation of the acid labile subunit gene in mice results in mild retardation of postnatal growth despite profound disruptions in the circulating insulin-like growth factor systemNuclear actions of insulin-like growth factor binding protein-3IGF binding proteins in cancer: mechanistic and clinical insightsInsulin-like growth factor-binding protein 5 complexes with the acid-labile subunit. Role of the carboxyl-terminal domainInsulin-like growth factor-binding protein 5 (Igfbp5) compromises survival, growth, muscle development, and fertility in miceN-Linked glycosylation and sialylation of the acid-labile subunit. Role in complex formation with insulin-like growth factor (IGF)-binding protein-3 and the IGFsInsulin-like growth factor binding proteins: a structural perspective.Cellular actions of insulin-like growth factor binding proteins.Defining elastic fiber interactions by molecular fishing: an affinity purification and mass spectrometry approach.Targeting insulin-like growth factor-I and insulin-like growth factor-binding protein-3 signaling pathways. A novel therapeutic approach for asthmaModulation of the somatotropic axis in periparturient dairy cows.Insulin-like growth factor-I regulation of immune function: a potential therapeutic target in autoimmune diseases?Growth factors and their receptors in pancreatic cancer.Eighteen insulin-like growth factor pathway genes, circulating levels of IGF-I and its binding protein, and risk of prostate and breast cancerThe insulin-like growth factor system: towards clinical applications.Insulin-like growth factor binding protein-5 in osteogenesis: facilitator or inhibitor?Do insulin-like growth factor associated proteins qualify as a tumor marker? Results of a prospective study in 163 cancer patients.Insulin-like growth factor (IGF) binding protein-5 blocks skeletal muscle differentiation by inhibiting IGF actionsInsulin-like growth factor-binding protein-5 (IGFBP-5): a critical member of the IGF axis.The therapeutic potential of insulin-like growth factor-1 in central nervous system disorders.Multifunctional roles of insulin-like growth factor binding protein 5 in breast cancer.Genomewide meta-analysis identifies loci associated with IGF-I and IGFBP-3 levels with impact on age-related traits.Recombinant human IGF-1 (insulin-like growth factor) therapy: where do we stand today?Calcium deficiency-induced and TRP channel-regulated IGF1R-PI3K-Akt signaling regulates abnormal epithelial cell proliferationIGFBP-2 nuclear translocation is mediated by a functional NLS sequence and is essential for its pro-tumorigenic actions in cancer cells.Insulin-like growth factor binding protein 5 enhances survival of LX2 human hepatic stellate cellsEffect of transgenic human insulin-like growth factor-1 on spinal motor neurons following peripheral nerve injury.D440N mutation in the acid-labile subunit of insulin-like growth factor complexes inhibits secretion and complex formationRegulation of the acid-labile subunit in sustained endotoxemia.Associations of insulin-like growth factors, insulin-like growth factor binding proteins and acid-labile subunit with coronary heart disease.Interaction of insulin-like growth factor II (IGF-II) with multiple plasma proteins: high affinity binding of plasminogen to IGF-II and IGF-binding protein-3.Insulin-like growth factor (IGF)-I binding to a cell membrane associated IGF binding protein-3 acid-labile subunit complex in human anterior pituitary gland.Formation of the IGF:IGFBP3:ALS complexFormation of the IGF:IGFBP5:ALS complexNeuroprotective effect of ischemic postconditioning on sciatic nerve transection.Modified insulin-like growth factor 1 containing collagen-binding domain for nerve regeneration.PAPPA2 as a Therapeutic Modulator of IGF-I Bioavailability: in Vivo and in Vitro Evidence.Effect of insulin treatment on circulating insulin-like growth factor I and IGF-binding proteins in cats with diabetes mellitus
P2860
Q22253898-38FB889F-3F57-4E8D-A1BB-AABC4AA4937DQ24681712-730617CC-682D-46A5-B453-96C7F8550F99Q28080513-7284B392-9C95-4EDF-8FAD-CD0325CF8674Q28237971-264ED741-D4DA-4A52-B345-1B877DAF4A54Q28286453-F2043FF3-5736-4869-AD71-FFA49EDC8436Q28512324-76A019DE-4B64-432F-89AD-CA5A53A36104Q28616473-0D6779BD-81C4-47C1-B9E5-9A7FF80504F7Q30417447-DFDDABE9-B539-4A20-BC60-176F2C642EDDQ33607372-1EF761F1-5CED-4636-93CD-65ECEA050B7CQ33628905-F8330564-7905-4273-92C0-0C8ADECC8B78Q33756365-85022303-6E1D-4933-A7BC-51803D342D78Q33885456-3A343C6C-24A4-451E-9B53-896C2A23B015Q33890792-10B99EDD-1046-48E9-9D83-AE5B238D76C1Q34116893-8E24660D-6685-47E9-8FCB-50F08AA480D0Q34338886-85EA1C07-7961-4543-A684-69612B34C962Q35819252-99C9F7F8-48B7-40AC-8283-86CCD48EB0E5Q35942750-0EA635C2-ECA9-4C33-87F1-E2DE462999F0Q36105839-D9729E04-D08A-4ADE-9A68-F2571819E8CBQ36372649-4DC07297-8584-49A9-B0E4-1BA820AC44BCQ36417183-456F1A50-478B-439C-892D-9EC6B3B85953Q36684355-2492E0A1-F6CF-4636-8A8A-FAE58AA1A5B3Q36955081-CB4C7EC1-C8A1-4D2C-A2E7-47DC1724865FQ37235560-0B43BFE2-D6F5-42E7-8BA9-17B2A81447BAQ37957047-114CF381-5D11-4A8B-8806-7CF8EA5222FDQ38255328-F120090D-0765-4A5D-8377-F4F31C75AA74Q39189621-902BB671-7A0E-43CB-8BD2-1C434FCDAA26Q39488300-48BF665E-3DF1-49DA-ACC5-22629BD10A5EQ41555531-2899F62B-F282-40FD-B212-A823FD66F8D8Q42289648-C1CE627D-8F49-4D13-87D1-23C8AF668930Q44129308-042BA541-7CAD-4ACA-80FE-F01ED1A774DAQ45135523-1436D2BF-8C4C-49AE-A974-1551E4A4F70EQ45218824-130773CE-1C6A-4D14-9721-5A9BCBF124BAQ48544279-7763CB24-E818-4899-BED8-B7E34D710E37Q50296755-39815360-B712-4F74-A4D5-A6AEF22DBB13Q50296757-89190DBE-ADA8-4A66-AF0F-AD8241C370C5Q52603043-0086EC03-9A4D-4F9E-BF30-615B058219A7Q55008043-4546C4FE-BF2D-4D94-BF23-1D48E123CEFBQ55261233-EF4E6B51-3B20-4DF2-9F7F-F37FB3451A11Q57169054-F273EBDD-72F9-43E6-9A1B-8C816AA220F9
P2860
Insulin-like growth factor (IGF)-binding protein 5 forms an alternative ternary complex with IGFs and the acid-labile subunit
description
1998 nî lūn-bûn
@nan
1998 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մարտին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
name
Insulin-like growth factor (IG ...... Fs and the acid-labile subunit
@ast
Insulin-like growth factor (IG ...... Fs and the acid-labile subunit
@en
Insulin-like growth factor (IG ...... Fs and the acid-labile subunit
@en-gb
Insulin-like growth factor (IG ...... Fs and the acid-labile subunit
@nl
type
label
Insulin-like growth factor (IG ...... Fs and the acid-labile subunit
@ast
Insulin-like growth factor (IG ...... Fs and the acid-labile subunit
@en
Insulin-like growth factor (IG ...... Fs and the acid-labile subunit
@en-gb
Insulin-like growth factor (IG ...... Fs and the acid-labile subunit
@nl
prefLabel
Insulin-like growth factor (IG ...... Fs and the acid-labile subunit
@ast
Insulin-like growth factor (IG ...... Fs and the acid-labile subunit
@en
Insulin-like growth factor (IG ...... Fs and the acid-labile subunit
@en-gb
Insulin-like growth factor (IG ...... Fs and the acid-labile subunit
@nl
P921
P3181
P356
P1476
Insulin-like growth factor (IG ...... Fs and the acid-labile subunit
@en
P2093
P304
P3181
P356
10.1074/JBC.273.11.6074
P407
P577
1998-03-01T00:00:00Z